Medicina Baseada em Evidências
Consenso | A técnica Delphi.
20 Jan, 2022 | 19:36hComing to consensus: the Delphi technique – European Journal of Cardiovascular Nursing
Análise | Sarcopenia: prevenção precoce ou “overdiagnosis”?
20 Jan, 2022 | 16:13hSarcopenia: early prevention or overdiagnosis? – The BMJ
Conteúdo relacionado: Overdiagnosis: it’s official – the term is now included in the medical subject headings (MeSH) vocabulary. (vários artigos sobre o tema)
Comentário do autor no Twitter
We have a new diagnosis! 2 billion people may turn into patients with sarcopenia. Despite no evidence to justify why we should diagnose elderly people. My latest article in @bmj_latest with @drjohnbrodersen and JBülow. #overdiagnosis #sarcopenia #EBM https://t.co/mNFxmuz4U1
— Christoffer Bjerre Haase (@BjerreHaase) January 13, 2022
Diretriz do Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022): orientação atualizada sobre relatórios de avaliações econômicas em saúde.
13 Jan, 2022 | 20:44hPerspectiva | O que a mais recente batalha judicial do Sci-Hub significa para a pesquisa.
13 Jan, 2022 | 11:36hWhat Sci-Hub’s latest court battle means for research – Nature
Decisões médicas: algumas são fáceis; outras, nem tanto.
12 Jan, 2022 | 12:48hMedical Decisions: Some are Easy and Some Not So Much – Stop and Think blog, by John Mandrola
Comentário no Twitter
Preventive therapy reduces the probability of a negative outcome. There are 2 big snags with preventive therapy:
1. All medical interventions come with the potential for harm.
2. Preventive therapies have modest effect sizes.
great read by @drjohnm https://t.co/Hk8VPnUv3m— Tjasa Zajc (@zajctjasa) January 9, 2022
5 coisas que aprendemos sobre revisão por pares em revistas científicas em 2021.
10 Jan, 2022 | 12:06h5 Things We Learned About Journal Peer Review in 2021 – Absolutely Maybe Blog, by Hilda Bastian
Conteúdos relacionados:
A billion-dollar donation: estimating the cost of researchers’ time spent on peer review.
The $450 question: Should journals pay peer reviewers?
Opinion: Peer reviewers—time for mass rebellion?
5 things we learned about peer review in 2020
Editorial: Evaluation and Peer Review During a Pandemic
Retrospectiva: principais artigos de 2021 sobre doenças infecciosas além da COVID.
17 Dez, 2021 | 12:06hYear In Review: Top Non-COVID Infectious Diseases Articles Of 2021 – IDStewardship
Comentário no Twitter
🔥🔥NEW 🔥🔥
My new post a great collaboration w the amazing @IDstewardship
Year In Review: Top✨ Non-COVID Infectious Diseases Articles Of 2021
18 high quality 🆔 RCTs
6 RCTs @NEJM#Shorterisbetter #IDTwitter #MedEd #TwitteRx #ASPchat #SoMeDocs
Others🤔https://t.co/wJtdjYJ0Gf pic.twitter.com/ugILKX5RQO— Antibiotic Stewa®️x🆔 Bassam Ghanem (@ABsteward) December 17, 2021
Revisão revela que as diretrizes sobre Covid são baseadas em evidências fracas.
16 Dez, 2021 | 13:05hReview uncovers weak COVID clinical practice guidelines – CIDRAP
Comentário no Twitter
This systematic review found that few clinical practice guidelines for pharmacologic treatment of hospitalized patients with #COVID19 met the National Academy of Medicine standards for trustworthy guidelines. https://t.co/nOCDp4pJWx
— JAMA Network Open (@JAMANetworkOpen) December 10, 2021
Opinião | Tomadores de decisão precisam constantemente de síntese de evidência atualizada.
16 Dez, 2021 | 12:41hDecision makers need constantly updated evidence synthesis – Nature